Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes

被引:1
作者
Igudesman, Daria [1 ,3 ,9 ]
Crandell, Jamie [2 ]
Corbin, Karen D. [3 ]
Zaharieva, Dessi P. [4 ]
Addala, Ananta [4 ]
Thomas, Joan M. [1 ]
Bulik, Cynthia M. [1 ,5 ,6 ]
Pence, Brian W. [7 ]
Pratley, Richard E. [3 ]
Kosorok, Michael R. [2 ]
Maahs, David M. [4 ]
Carroll, Ian M. [1 ]
Mayer-Davis, Elizabeth J. [1 ,8 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA
[3] AdventHlth Translat Res Inst, Orlando, FL 32804 USA
[4] Stanford Univ, Div Endocrinol, Dept Pediat, Stanford, CA 94304 USA
[5] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[6] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[7] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA
[8] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[9] AdventHlth Translat Res Inst, 301 E Princeton St, Orlando, FL 32804 USA
关键词
Type; 1; diabetes; Disordered eating; Insulin restriction; Gut microbiota; Short-chain fatty acids; Obesity; GUT MICROBIOTA; ANOREXIA-NERVOSA; FECAL MICROBIOTA; WEIGHT-GAIN; BODY-WEIGHT; COMPLICATIONS; OBESITY; PERMEABILITY; DIVERSITY; BACTERIA;
D O I
10.1016/j.numecd.2022.11.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Disordered eating (DE) in type 1 diabetes (T1D) includes insulin restriction for weight loss with serious complications. Gut microbiota-derived short chain fatty acids (SCFA) may benefit host metabolism but are reduced in T1D. We evaluated the hypothesis that DE and insulin restriction were associated with reduced SCFA-producing gut microbes, SCFA, and intestinal microbial diversity in adults with T1D. Methods and results: We collected stool samples at four timepoints in a hypothesis-generating gut microbiome pilot study ancillary to a weight management pilot in young adults with T1D. 16S ribosomal RNA gene sequencing measured the normalized abundance of SCFA-producing in-testinal microbes. Gas-chromatography mass-spectrometry measured SCFA (total, acetate, buty-rate, and propionate). The Diabetes Eating Problem SurveydRevised (DEPS-R) assessed DE and insulin restriction. Covariate-adjusted and Bonferroni-corrected generalized estimating equa-tions modeled the associations. COVID-19 interrupted data collection, so models were repeated restricted to pre-COVID-19 data. Data were available for 45 participants at 109 visits, which included 42 participants at 65 visits pre-COVID-19. Participants reported restricting insulin "At least sometimes" at 53.3% of visits. Pre-COVID-19, each 5-point DEPS-R increase was associated with a-0.34 (95% CI-0.56,-0.13, p = 0.07) lower normalized abundance of genus Anaerostipes; and the normalized abundance of Lachnospira genus was-0.94 (95% CI-1.5,-0.42), p = 0.02 lower when insulin restriction was reported "At least sometimes" compared to "Rarely or Never".Conclusion: DE and insulin restriction were associated with a reduced abundance of SCFA-producing gut microbes pre-COVID-19. Additional studies are needed to confirm these associa-tions to inform microbiota-based therapies in T1D. 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Ital-ian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:388 / 398
页数:11
相关论文
共 84 条
  • [1] Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients
    Armougom, Fabrice
    Henry, Mireille
    Vialettes, Bernard
    Raccah, Denis
    Raoult, Didier
    [J]. PLOS ONE, 2009, 4 (09):
  • [2] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [3] MULTIPLE SIGNIFICANCE TESTS - THE BONFERRONI METHOD .10.
    BLAND, JM
    ALTMAN, DG
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6973) : 170 - 170
  • [4] Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study
    Boets, Eef
    Gomand, Sara V.
    Deroover, Lise
    Preston, Tom
    Vermeulen, Karen
    De Preter, Vicky
    Hamer, Henrike M.
    Van den Mooter, Guy
    De Vuyst, Luc
    Courtin, Christophe M.
    Annaert, Pieter
    Delcour, Jan A.
    Verbeke, Kristin A.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2017, 595 (02): : 541 - 541
  • [5] Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
    Brown, Christopher T.
    Davis-Richardson, Austin G.
    Giongo, Adriana
    Gano, Kelsey A.
    Crabb, David B.
    Mukherjee, Nabanita
    Casella, George
    Drew, Jennifer C.
    Ilonen, Jorma
    Knip, Mikael
    Hyoty, Heikki
    Veijola, Riitta
    Simell, Tuula
    Simell, Olli
    Neu, Josef
    Wasserfall, Clive H.
    Schatz, Desmond
    Atkinson, Mark A.
    Triplett, Eric W.
    [J]. PLOS ONE, 2011, 6 (10):
  • [6] Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
  • [7] Effects of short chain fatty acids on metabolic and inflammatory processes in human health
    Campos-Perez, Wendy
    Martinez-Lopez, Erika
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2021, 1866 (05):
  • [8] Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
    Candela, Marco
    Biagi, Elena
    Soverini, Matteo
    Consolandi, Clarissa
    Quercia, Sara
    Severgnini, Marco
    Peano, Clelia
    Turroni, Silvia
    Rampelli, Simone
    Pozzilli, Paolo
    Pianesi, Mario
    Fallucca, Francesco
    Brigidi, Patrizia
    [J]. BRITISH JOURNAL OF NUTRITION, 2016, 116 (01) : 80 - 93
  • [9] Short-chain fatty acids in control of body weight and insulin sensitivity
    Canfora, Emanuel E.
    Jocken, Johan W.
    Blaak, Ellen E.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (10) : 577 - 591
  • [10] Patient-Centered Care for Obesity: How Health Care Providers Can Treat Obesity While Actively Addressing Weight Stigma and Eating Disorder Risk
    Cardel, Michelle, I
    Newsome, Faith A.
    Pearl, Rebecca L.
    Ross, Kathryn M.
    Dillard, Julia R.
    Miller, Darci R.
    Hayes, Jacqueline F.
    Wilfley, Denise
    Keel, Pamela K.
    Dhurandhar, Emily J.
    Balantekin, Katherine N.
    [J]. JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2022, 122 (06) : 1089 - 1098